HomeCompareRMD vs CEQP

RMD vs CEQP: Dividend Comparison 2026

RMD yields 1.06% · CEQP yields 9.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CEQP wins by $142.1K in total portfolio value
10 years
RMD
RMD
● Live price
1.06%
Share price
$220.03
Annual div
$2.33
5Y div CAGR
35.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.7K
Annual income
$3,288.25
Full RMD calculator →
CEQP
CEQP
● Live price
9.27%
Share price
$28.26
Annual div
$2.62
5Y div CAGR
25.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$173.8K
Annual income
$54,802.53
Full CEQP calculator →

Portfolio growth — RMD vs CEQP

📍 CEQP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRMDCEQP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RMD + CEQP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RMD pays
CEQP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RMD
Annual income on $10K today (after 15% tax)
$90.01/yr
After 10yr DRIP, annual income (after tax)
$2,795.01/yr
CEQP
Annual income on $10K today (after 15% tax)
$788.04/yr
After 10yr DRIP, annual income (after tax)
$46,582.15/yr
At 15% tax rate, CEQP beats the other by $43,787.14/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RMD + CEQP for your $10,000?

RMD: 50%CEQP: 50%
100% CEQP50/50100% RMD
Portfolio after 10yr
$102.8K
Annual income
$29,045.38/yr
Blended yield
28.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on RMD right now

RMD
Analyst Ratings
16
Buy
14
Hold
5
Sell
Consensus: Buy
Price Target
$295.88
+34.5% upside vs current
Range: $265.00 — $345.00
Altman Z
11.6
Piotroski
7/9
CEQP
Analyst Ratings
8
Buy
9
Hold
1
Sell
Consensus: Hold
Price Target
$33.00
+16.8% upside vs current
Range: $28.00 — $35.00
Altman Z
1.3
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RMD buys
0
CEQP buys
12
PoliticianChamberTickerTypeAmountDate
Bill Hagerty🏛 Senate$CEQP▼ Sell$50,001 - $100,0002023-11-06
Mark Dr Green🏢 House$CEQP▼ Sell$250,001 - $500,0002020-12-10
Mark Dr Green🏢 House$CEQP▲ Buy$100,001 - $250,0002020-11-23
Mark Dr Green🏢 House$CEQP▼ Sell$100,001 - $250,0002020-10-22
Mark Dr Green🏢 House$CEQP▲ Buy$100,001 - $250,0002020-10-22
Mark Dr Green🏢 House$CEQP▲ Buy$15,001 - $50,0002020-10-05
Mark Dr Green🏢 House$CEQP▼ Sell$100,001 - $250,0002020-09-11
Mark Dr Green🏢 House$CEQP▲ Buy$15,001 - $50,0002020-08-28
Mark Dr Green🏢 House$CEQP▲ Buy$15,001 - $50,0002020-08-12
Mark Dr Green🏢 House$CEQP▲ Buy$15,001 - $50,0002020-08-11
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRMDCEQP
Forward yield1.06%9.27%
Annual dividend / share$2.33$2.62
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR35.9%25.6%
Portfolio after 10y$31.7K$173.8K
Annual income after 10y$3,288.25$54,802.53
Total dividends collected$10.4K$137.2K
Payment frequencyquarterlyquarterly
SectorHealthcareStock
Analyst consensusBuyHold
Analyst price target$295.88$33.00

Year-by-year: RMD vs CEQP ($10,000, DRIP)

YearRMD PortfolioRMD Income/yrCEQP PortfolioCEQP Income/yrGap
1← crossover$10,844$143.91$11,864$1,164.44$1.0KCEQP
2$11,801$198.21$14,317$1,621.71$2.5KCEQP
3$12,901$273.96$17,616$2,297.06$4.7KCEQP
4$14,185$380.39$22,167$3,317.73$8.0KCEQP
5$15,709$531.20$28,619$4,900.54$12.9KCEQP
6$17,556$747.16$38,049$7,426.80$20.5KCEQP
7$19,845$1,060.53$52,303$11,590.39$32.5KCEQP
8$22,757$1,522.63$74,666$18,701.89$51.9KCEQP
9$26,567$2,217.64$111,232$31,339.23$84.7KCEQP
10$31,715$3,288.25$173,821$54,802.53$142.1KCEQP

RMD vs CEQP: Complete Analysis 2026

RMDHealthcare

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Full RMD Calculator →

CEQPStock

Crestwood Equity Partners LP develops, acquires, owns, controls, and operates assets and operations in the energy midstream sector in the United States. It operates through three segments: Gathering and Processing North; Gathering and Processing South; and Storage and Logistics. The Gathering and Processing North segment offers natural gas, crude oil, and produced water gathering, compression, treating, processing, and disposal services to producers in the Williston Basin and Powder River Basin. This segment owns and operates natural gas facilities with approximately 0.4 Bcf/d of gathering capacity and 0.5 Bcf/d of processing capacity; crude oil facilities with approximately 150,000 Bbls/d of gathering capacity and 266,000 Bbls of storage capacity; and produced water facilities with approximately 130,000 Bbls/d of gathering and disposal capacity. The Gathering and Processing South segment provides natural gas gathering, compression, treating, and processing; and produced water gathering and disposal services to producers in the Marcellus, Barnett, and Delaware basins. This segment owns and operates natural gas facilities with 2.5 Bcf/d of gathering capacity and 0.7 Bcf/d of processing capacity; and produced water facilities with approximately 75,000 Bbls/d of gathering and disposal capacity. The Storage and Logistics segment offers natural gas liquids, crude oil, and natural gas storage, terminal, marketing, and transportation, including rail, truck and pipeline services to producers, refiners, marketers, utilities, and other customers. Crestwood Equity GP LLC serves as the general partner of Crestwood Equity Partners LP. The company was formerly known as Inergy L.P. and changed its name to Crestwood Equity Partners LP in October 2013. Crestwood Equity Partners LP was incorporated in 2001 and is headquartered in Houston, Texas.

Full CEQP Calculator →
📬

Get this RMD vs CEQP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RMD vs SCHDRMD vs JEPIRMD vs ORMD vs KORMD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.